Junling Li

Academic / Other · 3 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Camrelizumab Plus Apatinib for Advanced Non-Squamous NSCLC Previously Treated With First-Line Immunotherapy Advanced Non Squamous NSCLC	Phase 2	2021-06-28
Unknown	Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemoth Extensive-Stage Small Cell Lung Cancer	Phase 2	2019-08-05
Unknown	The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Ca Apatinib in Maintenance Treatment	Phase 2	2017-04-11